TDM in Saxonia (Germany).

Conca et al. complain insufficient TD use in Italy. This survey suggests that the situation and possibly also the reasons are similar in the German Federal Republic.

Bright light treatment as mono-therapy of non-seasonal depression for 28 adolescents.

Background: Bright light therapy, an effective therapeutic option for depressive adults, could provide safe, economic, and effective rapid recovery also in adolescents.

Methods: Twenty-eight volunteers, between 14 and 17 years old and suffering from mild depressive disorder according to DSM-IV criteria, completed the study. This was a randomized cross-over trial, i.

Agomelatine treatment with adolescents with ADHD.

Objective: Antidepressants, in particular Atomextine, along with stimulants have demonstrated benefit in the treatment of ADHD. Agomelatine is a new antidepressant with additional affinities to the melatonergic system. As ADHD has been associated with sleep disorders, it is assumed that Agomelatiine might serve as a therapeutic alternative to treat patients with the ADHD refractory to first line medications.

Treating ADHD with agomelatine.

Objective: Agomelatine is a relatively new antidepressant, with affinities to MT1 and MT2 (responsible for the circadian rhythm) as well as to 5-HT2C receptors. Since antidepressants have demonstrated some benefit in the treatment of ADH and because of the fact, that ADHD is often associated with sleep disorders, we assumed, that it might be a therapeutic alternative also for ADHD.

Method: We proved this assumption in ten ADHD patients in a placebo controlled manner.

Additional biological therapies for attention-deficit hyperactivity disorder: repetitive transcranical magnetic stimulation of 1 Hz helps to reduce methylphenidate.

Excessive hyperactivity, impulsiveness and attentional difficulties characterize attention-deficit hyperactivity disorder (ADHD). The aim of this case report is to signal the possible therapeutic effectiveness of the repetitive transcranial magnetic stimulation (rTMS). Low frequency (1Hz, 1200 stim/die for five days) was applied on the impending scalp in the motor additional area of a patient suffering from combined type ADHD who received methylphenidate (MPH).

Association of attention-deficit/hyperactivity disorder and celiac disease: a brief report.

Objective: A possible association of celiac disease with psychiatric and psychological disturbances such as attention-deficit/hyperactivity disorder (ADHD) has been reported repeatedly. The objective of this study was to observe whether a gluten-free diet could alleviate the behavioral symptoms in patients with celiac disease and ADHD.

Method: Sixty-seven subjects aged 7 to 42 years (mean = 11.

Developing biochemical profiles for various psychiatric diseases.

It is well known, that most of the psychiatric diseases affect various neurotransmitter systems. It is the aim of this profile to define a set of cheap analyses, indicative for a specific psychiatric disease, to facilitate differential diagnosis and to offer an additional tool to the already existing clinical-descriptive methods.

Bright light treatment as add-on therapy for depression in 28 adolescents: a randomized trial.

Background: In the last decade, a significant incidence of depression in the younger population has been observed. Bright light therapy, an effective therapeutic option for depressed adults, could also provide safe, economical, and effective rapid recovery in adolescents.

Method: The randomized trial included 28 inpatients (18 females and 10 males) between 14 and 17 years old with depressive complaints.

[Patient satisfaction with outpatient psychological services].

A validated questionnaire regarding patient satisfaction with psychological services is reported. There is a German and an Italian version, with a total sample size of 655 persons. Based on satisfaction criteria generated by the patients themselves, a preliminary version and consecutively the final version, computed according to psychometric criteria, were developed.

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Background: Attention deficit hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that persists into adulthood in the majority of cases. The evidence on persistence poses several difficulties for adult psychiatry considering the lack of expertise for diagnostic assessment, limited treatment options and patient facilities across Europe.

Methods: The European Network Adult ADHD, founded in 2003, aims to increase awareness of this disorder and improve knowledge and patient care for adults with ADHD across Europe.

St. John's wort may improve some symptoms of attention-deficit hyperactivity disorder.

There is evidence for the efficacy of noradrenaline and serotonin reuptake inhibitors treating attention-deficit hyperactivity disorder (ADHD). In this open trial, we checked St. John's wort, a serotonin and noradrealine reuptake inhibitor, and actually used as an antidepressant, for this indication.